Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
16.12
+0.32 (+2.03%)
Official Closing Price
Updated: 7:00 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Organon & Co.
< Previous
1
2
3
4
5
6
Next >
Healthy Pharma Favorites
March 25, 2022
Here's a look at two drug makers that we recommend in our Growth & Income Portfolio. The stocks in this portfolio are generally higher-quality, larger-cap companies that have fallen out of favor.
Via
Talk Markets
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
March 09, 2022
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 21, 2022
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
World Markets News For Thursday
February 17, 2022
Ericsson stock lost another 5.27% today in US markets.
Via
Talk Markets
Merck Spinoff Organon Beats Quarterly Views, But Offers Dim Guidance
February 17, 2022
Organon's sales and earnings fell less than expected, but 2022 sales guidance missed.
Via
Investor's Business Daily
Earnings Scheduled For February 17, 2022
February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Via
Benzinga
Earnings Scheduled For November 11, 2021
November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...
Via
Benzinga
Expert Ratings For Organon
October 07, 2021
Analysts have provided the following ratings for Organon (NYSE:OGN) within th...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Organon
September 01, 2021
Organon (NYSE:OGN) has observed the following analyst ratings within the last...
Via
Benzinga
Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto $6.4B
February 17, 2022
Organon & Co's (NYSE: OGN) Q4 FY21 sales decreased 1% to $1.6 billion, beating the consensus of $1.57 billion. Women's Health increased 6%, driven primarily...
Via
Benzinga
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Warren Buffett Is Selling These Stocks
November 30, 2021
Looking to make money moves like Warren Buffett? Want to know which stocks Buffett is selling? Interested in finding out why these stock sales might be a huge mistake?
Via
Talk Markets
Tuesday Markets Coverage
November 23, 2021
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.
Via
Talk Markets
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG...
Via
Benzinga
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
Spin-off stocks can be lucrative for shareholders in both legacy businesses and recently created public companies. Here are three to know.
Via
InvestorPlace
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
Warren Buffett's Berkshire Hathaway Inc (NYSE: BRK-A) cleared its stake in Merck & Co Inc (NYSE: MRK) in Q3, right on the eve of a significant stock...
Via
Benzinga
Warren Buffet Takes A Stake In Royalty Pharma And Exits Merck — What You Need To Know
November 16, 2021
Warren Buffet's Berkshire Hathaway added more than 13 million shares.
Via
Investor's Business Daily
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
Veteran's Day
November 11, 2021
Stock markets took a tumble today across the board, but not as far down as at the opening.
Via
Talk Markets
Lower Sales Impact Organon's Q3 Margins; Acquires Forendo Pharma For Over $900M
November 11, 2021
Organon & Co (NYSE: OGN) has reported Q3 sales of $1.6 billion, down 1% Y/Y, slightly higher than the consensus of $1.58 billion. Women's Health declined...
Via
Benzinga
Organon Beat Quarterly Forecasts, Unveiled Takeover — Here's Why Shares Fell
November 11, 2021
Organon topped forecasts on Thursday and announced its plan to buy Forendo Pharma.
Via
Investor's Business Daily
Why Merck's Strong Outlook For 2021 Could Become Even More Bullish
October 28, 2021
Merck issued upbeat guidance for 2021 that could grow if Covid pill molnupiravir gains authorization.
Via
Investor's Business Daily
Europe's Unicorns
October 15, 2021
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
Upgrades For State Street Corporation (NYSE:
Via
Benzinga
Top Stocks Warren Buffett Just Bought
August 18, 2021
These were Berkshire Hathaway's biggest buys during Q2, 2021.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
September 01, 2021
Upgrades For Chatham Lodging Trust (NYSE:
Via
Benzinga
Friday the Thirteenth
August 13, 2021
The stock week in points eastward was mixed. The USA markets face a bear correction.
Via
Talk Markets
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
August 17, 2021
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...
Via
Benzinga
Merck Spinoff Organon Just Reported Its First Quarter — Here's What You Need To Know
August 12, 2021
Organon crushed Wall Street's second-quarter expectations on Thursday and announced its first dividend, leading OGN stock to pop.
Via
Investor's Business Daily
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.